Spruce BiosciencesSPRB
13F holders, Q4 2024 (December 31)31holders +1
6new positions
4sold out
1famous investor
$0.42avg. 13F price*
At the end of Q4 2024, 31 institutions reported holding Spruce Biosciences Inc. (SPRB) in their 13F filings, up 1 from Q3 2024. 6 opened new positions and 4 sold out. The largest holders were Carlyle Group Inc. ($1.2M), Rock Springs Capital Management LP ($1.1M) and Acadian Asset Management LLC ($437K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Spruce Biosciences Inc.
- CUSIP
- 85209E109
- Latest filing quarter
- Q2 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $583K |
| Exits | 4 | $234K |
All 13F filers, Q3 2024 → Q4 2024: 1,510,436 shares bought and 1,008,188 shares sold, net +502,248 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 31 holders
| Carlyle Group Inc. | 0.03% | No change | 2,896,518 | $1.2M |
| Rock Springs Capital Management LP | 0.04% | No change | 2,609,125 | $1.1M |
| Acadian Asset Management LLC | 0.00% | Reduce -16.9% | 1,045,828 | $437K |
| Ikarian Capital, LLC | 0.12% | New | 1,000,000 | $420K |
| Vanguard Group Inc. | 0.00% | No change | 843,844 | $354K |
| Sands Capital Alternatives, LLC | 0.07% | Reduce -9.1% | 715,817 | $301K |
| Renaissance Technologies | 0.00% | Reduce -33.4% | 405,900 | $170K |
| ADAR1 Capital Management, LLC | 0.04% | No change | 403,716 | $170K |
| Boothbay Fund Management, LLC | 0.00% | New | 288,800 | $121K |
| Geode Capital Management, LLC | 0.00% | Add +4.5% | 273,785 | $115K |
| BlackRock, Inc. | 0.00% | No change | 124,734 | $52K |
| UBS Group AG | 0.00% | Add +661784.6% | 86,045 | $36K |
| Northern Trust Corp. | 0.00% | Add +7.2% | 80,308 | $34K |
| Lion Point Capital, LP | 0.16% | No change | 75,000 | $32K |
| State Street Corp. | 0.00% | Reduce -5.8% | 60,700 | $25K |
| Susquehanna International Group, LLP | 0.00% | New | 58,984 | $25K |
| Shay Capital LLC | 0.00% | No change | 38,119 | $16K |
| HRT Financial LP | 0.00% | New | 37,838 | $15K |
| XTX Topco Ltd | 0.00% | Add +85.8% | 35,549 | $15K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -12.8% | 34,900 | $15K |
| Two Sigma Investments, LP | 0.00% | Reduce -11.8% | 20,616 | $9K |
| Marex Group Ltd | 0.00% | No change | 14,800 | $6K |
| Two Sigma Advisers, LP | 0.00% | Reduce -49.1% | 13,800 | $6K |
| Simplex Trading, LLC | 0.00% | New | 4,857 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2.4% | 4,761 | $2K |
| Morgan Stanley | 0.00% | No change | 2,133 | $896 |
| Group One Trading LLC | 0.00% | Reduce -53.9% | 1,769 | $743 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1,000 | $420 |
| Bank of America Corp. | 0.00% | Reduce -0.5% | 222 | $93 |
| BNP Paribas Financial Markets | 0.00% | New | 181 | $76 |
| JPMorgan Chase & Co. | 0.00% | Reduce -2.8% | 69 | $29 |
"% of holder's portfolio" is SPRB's weight in each manager's 13F, not the share of Spruce Biosciences Inc. the manager owns.